Thrombosis news, opinions and education

heartwire News

  • ESC Data Bolster Dual Antithrombotic Therapy in AF PCI Patients A new study supports forgoing traditional triple antithrombotic therapy with aspirin for dual therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation who've undergone PCI.
  • ESC ESC Guideline Update on Dual Antiplatelet Therapy in CAD The latest advice in this controversial area advocates a personalized-medicine approach based on ischemic vs bleeding risks, where each treatment and its duration is individualized as much as possible.
  • PFO Closure Reduces Stroke Recurrence Three new studies provide evidence that closure of patent foramen ovale in select patients after cryptogenic stroke reduced the stroke recurrence rate compared with medical therapy.
  • ESC Apixaban Advantage Before AF Cardioversion Hinted: EMANATE Bolus dosing of apixaban allowed cardioversion in 2 or more hours in patients with mostly recent-onset atrial fibrillation; TEE or other atrial imaging was not always performed.

Perspective